Search

Home > Voices In Validation > Compounding. Compliance. COVID. The impact of temporary FDA guidance now, and in the future.
Podcast: Voices In Validation
Episode:

Compounding. Compliance. COVID. The impact of temporary FDA guidance now, and in the future.
Category: Science & Medicine
Duration: 01:07:11
Publish Date: 2020-06-23 04:00:00
Description:

Stacey Bruzzese welcomes Eric Kastango to the show. Today, Stacey and Eric discuss the how FDA has implemented temporary guidelines and how companies can mitigate their risks to consumers and compounding sites.

Eric has dedicated his life’s work to patient safety through better sterile compounding, aseptic manufacturing, lean production, and robust quality management practices. has practiced pharmacy in hospital, community, and homecare settings in a variety of roles. He was previously Corporate Vice President of Pharmacy Services for Coram Healthcare and also managed a cGMP outsource manufacturing operation for Baxter Healthcare. In addition to his consulting role, Eric continues to serve as a sterile compounding, 503B outsourcing, and patient safety subject matter expert for his clients, the American Society of Health-System Pharmacists, State Boards of Pharmacy, and was one of the key US Department of Justice expert witnesses during the New England Compounding Center trials from 2017-2019.

Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.
Total Play: 0